Paris, France

Claude Monneret

USPTO Granted Patents = 15 

Average Co-Inventor Count = 6.8

ph-index = 7

Forward Citations = 285(Granted Patents)


Company Filing History:


Years Active: 1990-2008

Loading Chart...
15 patents (USPTO):Explore Patents

Title: Claude Monneret: A Pioneer in Pharmaceutical Innovations

Introduction

Claude Monneret is a distinguished inventor based in Paris, France. He has made significant contributions to the field of pharmaceuticals, holding a total of 15 patents. His work primarily focuses on the development of innovative compounds with therapeutic applications.

Latest Patents

Monneret's latest patents include the development of 9-amino-podophyllotoxin derivatives, which are crucial for producing pharmaceutical compositions. This invention relates to compounds that possess various functional groups, enhancing their efficacy in medical applications. Another notable patent involves pyridinone and pyridinethione derivatives that exhibit HIV inhibiting properties. These compounds are designed to provide effective treatment options for patients suffering from HIV, showcasing Monneret's commitment to addressing critical health challenges.

Career Highlights

Throughout his career, Monneret has worked with reputable companies such as Behringwerke Aktiengesellschaft and Laboratoires Hoechst S.A. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Monneret has collaborated with notable professionals in his field, including Jean-Claude Florent and Klaus Bosslet. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective projects.

Conclusion

Claude Monneret's contributions to pharmaceutical innovations are noteworthy, as evidenced by his numerous patents and collaborations. His work continues to impact the medical field positively, providing new avenues for treatment and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…